MedTrace Logo

Assisted Exercise in Obese Endometrial Cancer Patients

NCT01870947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2020-01-27

No results posted yet for this study

Summary

This is an assisted exercise trial involving exercise on a stationary bike, brain imaging and DNA(genetics)sampling. The purpose of this study is to find out if performing a progressive, supervised assisted exercise program on a stationary bike improves quality of life, increases motivation to continue to exercise, improves dietary behavior and leads to sustained weight loss in women who have had early-stage endometrial cancer. Questionnaires will be used to assess exercise motivation and dietary behavior. Brain's responses to different visual images will also be assessed.

Conditions

  • Stage I Endometrial Adenocarcinoma
  • Uterine Cancer
  • Obesity

Interventions

BEHAVIORAL

Exercise on stationary recumbent exercise cycle

BEHAVIORAL

Health Education

Informational brochure ("Better Health and You," Weight Control Information Network, June, 2004)

BEHAVIORAL

Questionnaires

PROCEDURE

Neuroimaging

Imaging data will be acquired on a Siemens 3.0T Wide-Bore Verio MRI scanner.

PROCEDURE

Genetic and Biomarkers

Patients will be asked to fast for approximately 12 hours and will have approximately 2 Tbs. of blood drawn at baseline and the end of treatment (EOT).

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Nora Nock, PhD · Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-07
Primary Completion
2019-09-04
Completion
2019-09-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870947 on ClinicalTrials.gov